P-235 E-health monitoring during pancreatic cancer treatment

Technologies of digital support for oncological patients through mobile applications is a trend. The so-called “e-health” already reality in hospitals across the world. WeCancer App an electronic patient-reported outcome tool, which also provides on-demand multidisciplinary from nurses, psychologists, and nutritionists. It encompasses real-time remote patient monitoring, notification center to medical staff, symptom medication control, content hub with reliable information. This study examined whether daily reporting (with outcomes [e-PROs]) pancreatic cancer feasible. Patients could report sixteen common symptoms application, on their smartphones tablets, management, follow-up specialized nurse, who determines care based clinical protocols online chat. nursing team action started at moment inclusion tutorial download training patient/caregiver. From January 2020 March 2021, 44 eligible were enrolled this study. e-PRO completion rates > 90% baseline, ≥ 50% all on-treatment assessments adherence. In adherence, 99 reports made. 53 (53,54%) symptoms, 14 (14,14%) sleep, 12 (12,12%) weight, 7 (7,07%) gratitude. most reported were: tiredness (18,87%), pain (16,98%), dysphagia (9,43%), nausea (7,55%). Pancreatic patients' are feasible e-health. results suggest that further research should be done prove effectiveness App.